Market Closed -
OTC Markets
19:09:03 06/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.023
USD
|
-28.57%
|
|
-28.57%
|
-25.81%
|
Fiscal Period: March |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
24.48
|
9.83
|
3.912
|
Enterprise Value (EV)
1 |
24.48
|
9.83
|
3.949
|
P/E ratio
|
-14.1
x
|
-2.35
x
|
-2.86
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
19,743,525,806
x
|
-
|
-
|
EV / Revenue
|
19,742,100,000
x
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
EV / FCF
|
299,837,149
x
|
-
|
9,520,027
x
|
FCF Yield
|
0%
|
-
|
0%
|
Price to Book
|
-44.1
x
|
-9.13
x
|
-1.78
x
|
Nbr of stocks (in thousands)
|
34,875
|
38,917
|
39,117
|
Reference price
2 |
0.7020
|
0.2526
|
0.1000
|
Announcement Date
|
18/07/22
|
18/07/22
|
14/07/23
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
0.00124
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.8265
|
-1.723
|
-3.928
|
-1.372
|
Operating Margin
|
-
|
-138,937.9%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.8734
|
-1.723
|
-3.928
|
-1.374
|
Net income
1 |
-0.8734
|
-1.723
|
-3.928
|
-1.374
|
Net margin
|
-
|
-138,937.18%
|
-
|
-
|
EPS
2 |
-0.0377
|
-0.0499
|
-0.1074
|
-0.0350
|
Free Cash Flow
|
-
|
0.0816
|
-
|
0.4148
|
FCF margin
|
-
|
6,584.27%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
09/12/20
|
18/07/22
|
18/07/22
|
14/07/23
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
0.04
|
Net Cash position
1 |
0.24
|
0
|
0
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0.08
|
-
|
0.41
|
ROE (net income / shareholders' equity)
|
-
|
807%
|
-
|
82.6%
|
ROA (Net income/ Total Assets)
|
-
|
-487%
|
-
|
-618%
|
Assets
1 |
-
|
0.3537
|
-
|
0.2222
|
Book Value Per Share
2 |
0.0100
|
-0.0200
|
-0.0300
|
-0.0600
|
Cash Flow per Share
2 |
0.0100
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
09/12/20
|
18/07/22
|
18/07/22
|
14/07/23
|
|
1st Jan change
|
Capi.
|
---|
| -25.81% | 922K | | -2.84% | 88.91B | | +2.76% | 41.25B | | -13.92% | 31.99B | | +50.51% | 24.73B | | -15.25% | 15.54B | | -39.93% | 12.07B | | -9.08% | 12.05B | | -14.80% | 12.02B | | +6.22% | 8.84B |
Biopharmaceuticals
|